Drug-coated balloon angioplasty versus conventional angioplasty for symptomatic non-acute intracranial artery occlusion

Background and objectiveNon-acute intracranial artery occlusion (ICAO) is an important cause of recurrent ischemic stroke despite aggressive medical treatment. Conventional angioplasty has high incidences of perioperative complications and restenosis in treating these patients. Drug-coated balloon (...

Full description

Saved in:
Bibliographic Details
Main Authors: Kaiyue Dong, Yingkun Chen, Yun Song, Lili Sun, Meimei Zheng, Hao Yin, Jun Zhang, Shuoshuo Li, Tianxi Yin, Wei Wang, Yao Meng, Weili Li, Xiao He, Chenlu Zhu, Wei Zhao, Ju Han
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1570728/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and objectiveNon-acute intracranial artery occlusion (ICAO) is an important cause of recurrent ischemic stroke despite aggressive medical treatment. Conventional angioplasty has high incidences of perioperative complications and restenosis in treating these patients. Drug-coated balloon (DCB) treatment has shown superiority in preventing restenosis. This study aimed to compare the DCB angioplasty with conventional angioplasty in symptomatic ICAO patients.MethodsFrom January 2016 to March 2024, consecutive patients with symptomatic non-acute ICAO treated with endovascular therapy were enrolled and dichotomized by whether DCB was used. Propensity score matching analysis was used to compare the perioperative complications, clinical and imaging follow-up results of the two groups.Results158 eligible patients were included in this study. There were 104 cases in the DCB group and 54 cases in the non-DCB group. A total of 92 matched patients were selected for propensity score matching analysis. At 6 months follow-up, the median stenosis degree (19.3% [0% ~ 34.3%] vs. 43.6% [22.8% ~ 80.2%], p = 0.009) and total restenosis incidence (10.9% [5/46] vs. 39.1% [18/46], p = 0.004) were significantly lower in the DCB group. There were no statistically significant differences in the incidences of perioperative complications (8.7% vs. 17.4%, p = 0.388), symptomatic restenosis (2.2% vs. 8.7%, p = 0.375) and recurrent ischemic events (4.3% vs. 10.9%, p = 0.453) between the two groups.ConclusionIn patients with symptomatic non-acute ICAO, compared with conventional angioplasty, DCB angioplasty can effectively reduce the restenosis degree and restenosis risk.
ISSN:1664-2295